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a b s t r a c t
Background: Pulmonary artery endarterectomy (PEA) is established as a successful method for
the treatment of chronic thromboembolic pulmonary hypertension (CTEPH). A signiﬁcant
fraction of patients indicated for the pulmonary endarterectomy has other severe comorbidities
thatgenerally increasetheriskofcardiacsurgery.Theaimofourstudyistoanalyzetheprocessof
indications and therapeutic procedures at our Cardio-Centre, as well as comparing hemody-
namicparametersandlong-termresults inordertodeterminethecontinuationofthetreatment.
Method: From September 2004 to August 2012, 192 patients underwent PEA for CTEPH. We
carried out a retrospective analysis of patients' data. Patients were divided into two groups:
A and B. The group A included patients with PEA only (128 patients), group B consisted of
patients with PEA and other cardiac procedure (64 patients, i.e. 33.3% of which 72 cardiac
procedures were carried out). Group B was further subdivided into group B1-patients with
PEA + CABG, which included 25 patients, and group B2-PEA + suture of PFO, which consisted
of 29 patients for more detailed analysis.
Results: Five-year survival rate is 83% in group A, 79.3% in group B, and 63.1% in group B1.
Group B1 is statistically signiﬁcantly different from group A (P = 0.031). The cumulative
survival rate is comparable for groups A and B2. Cumulative survival rate is very good with
annual survival in group A – 94%, group B2 – 90% and group B1 – 82.6%.
Conclusion: Results of combined interventions are comparable with isolated pulmonary
endarterectomy. Wedidnotﬁndanydifferencesinhemodynamiceffects.Allpatientsindicated
for the PEA should be screened for the most common comorbidities regardless of their age. We
recommend implementation CryoMAZE for the treatment of atrial ﬁbrillation or atrial ﬂutter.
# 2015 The Czech Society of Cardiology. Published by Elsevier Sp. z o.o. All rights
reserved.
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simultaneously with the PEA.
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Pulmonary artery endarterectomy (PEA) is established as a
successful method for the treatment of chronic thromboem-
bolic pulmonary hypertension (CTEPH). In a selected group of
patients, it can lead to the cure of this disease, which if left
untreated has an otherwise very poor prognosis as showed by
a number of studies. A signiﬁcant fraction of patients indicated
for the pulmonary endarterectomy have other severe comor-
bidities that generally increase the risk of cardiac surgery. As a
standard, the risk of cardiac surgery is calculated using scoring
systems such as the EuroSCORE II, STS score [1,2]. In order to
estimate the risk of PEA and PEA combined with other cardiac
procedures, we cannot use current scoring systems as they do
not take into account the risk factors for CTEPH and PEA. The
main risk factors for these procedures are the severity of PH,
heart failure, and the signiﬁcance of deterioration of other
organs functions [3]. Nearly 30% of our patients have renal
insufﬁciency, 29% ischemic heart disease, 10% atrial ﬂutter or
ﬁbrillation, 12% diabetes mellitus and 5% stroke. Patients with
CTEPH combined with cardiac disease account for different
portions in various published reports. In the latest report
published by the UCSD, PEA combined with CABG, suture of
the foramen ovale and valve surgeries is similar to our group of
patients, accounting for 30% [3]. Our group of patients contains
in addition procedures for atrial ﬁbrillation; all these proce-
dures in our group were performed in 33.3% of patients [4].
Data analysis by the UCSD shows excellent results and
comparable mortality in combined procedures as well as in
PEA only. However, CABG surgery combined with lung
transplantation or resections has signiﬁcantly worse results
[5].
In our report, we will concentrate mainly on the cardiac
diseases that can be solved simultaneously with pulmonary
hypertension. They are predominantly coronary artery dis-
ease, valvular defects, atrial septal defects, and atrial ﬁbrilla-
tion. The aim of our study is to analyze the process of
indications and therapeutic procedures at our Cardio-Centre,
as well as comparing hemodynamic parameters and long-
term results in order to determine the continuation of the
treatment.
Materials and methods
From September 2004 to August 2012, 192 patients underwent
PEA for CTEPH at 2nd Surgical Clinic of Cardiovascular Surgery,
General Faculty Hospital and 1st Faculty of Medicine after a
complex diagnostic examination at the 2nd Clinic of Internal
Medicine – Cardiology and Angiology, General University
Hospital and 1st Faculty of Medicine. All operations were
performed by one surgeon. Post-operative care was carried out
by doctors of both clinics with the addition of The Clinic of
Anesthesia, Resuscitation and Intensive Care (KARIM), General
Faculty Hospital and 1st Faculty of Medicine.
Indications for pulmonary endarterectomy included:
1. Symptomatic patients usually NYHA III or IV.
2. PVR greater than 320 dyn (4 Wj).3. Pulmonary lesion manifested on angiography or CT-AG.
4. Effective anticoagulation for at least 3 weeks.
Patients where combined etiology of PH was not dominant
to the CTEPH were contraindicated. Furthermore, we contra-
indicated patients with severe disease that signiﬁcantly
limited patient's survival (malignancy) and patients with
irreversible multi-organ dysfunction. We did not indicated any
uncooperative patients and patients in which a psychiatrist or
neurologist did not recommend the procedure.
We carried out a retrospective analysis of patient data.
Patients were divided into two groups: A and B. These groups
of patients were mutually analyzed. The group A included
patients with PEA only (128 patients), group B consisted of
patients with PEA and other cardiac procedure (64 patients, i.e.
33.3% of which 72 cardiac procedures were carried out). Table 1
shows the number of individual procedures in group B.
For detailed analysis of this group, we have dedicated group
B1-patients with PEA + CABG, which included 25 patients,
group B2-PEA + suture of PFO, which consisted of 29 patients.
The remaining 10 patients with combined procedure were not
subjected to a separate analysis due to its statistical insigniﬁ-
cance. The overall mortality was 5.2%, 3.9% in group A and
7.8% in group B.
Statistical analysis
All continuous variables were tested for normality using
Kolmogorov–Smirnov test. All normal variables were
expressed as mean  standard error of mean (SEM) and the
differences between groups were assessed by the one-way
ANOVA (for 3 groups) or independent samples t-test (for
2 groups). Analogically, all non-normal variables were repre-
sented by median (Min  Max) and the between-group
comparisons were performed using Kruskal–Wallis test or
Mann–Whitney test. Chi-square test was used for comparisons
of frequencies between groups in the case of categorical
variables. The variables measured pre- and post-operation
were analyzed using one-way ANCOVA with repeated mea-
sures. Survival distribution was estimated by the Kaplan–
Meier method. Signiﬁcant differences in the probability of
surviving between the groups were evaluated by the Gehan–
Wilcoxon test. Cox proportional hazard models were used to
identify risk factors for survival. All tests were performed in
Statistica 12 (StatSoft, Inc, Tulsa, OK, USA).
Operating procedures
All operations were performed through median sternotomy.
After cannulation, extracorporeal circulation was started.
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a standard manner; patient was cooled down to a 208 C. During
the cooling procedure superior vena cava was dissected in
order to access the right pulmonary artery, and if myocardial
revascularization was planned, than Great Saphenous Vein
and LIMA was harvested.
After cooling to 20 8C, the ascending aorta was cross-
clamped, 1000 ml of crystalloid cardioplegia was infused
through the aortic root into the coronary circulation (Custo-
diol, Kohler Pharma). We open the right branch of the
pulmonary artery between the aorta and the superior vena
cava. The incision was extended into the intermediate trunk if
necessary. Endarterium was dissected with Jamieson dissector
after cutting the wall with thin dissector in the correct part of
media. We were trying to dissect the appropriate layer
circularly. Due to the retrograde bleeding the dissection is
performed in circulatory arrest during which each segment is
completely freed from the endarterium. In peripheral seg-
ments, it is very important to ensure the proper spacing layer
in each segment separately.
After completing the desobliteration of all segments, the
extracorporeal circulation was started and suture of arter-
iotomy of the right pulmonary artery was performed in two
layers. On the left pulmonary artery, we proceed in above
described manner. Due to the short accessibility of left
branch, we perform the incision in the trunk of the
left pulmonary artery, and the incision was extended to the
left branch. Desobliteration was performed after extracorpo-
real circulation was stopped. After the completion of
endarterectomy extracorporeal circulation and heating pro-
cess of the patient were started. In the case of combined
procedures we performed peripheral anastomosis of coro-
nary bypasses, valve surgery or CRYOMAZE. Central coronary
bypass anastomosis was performed after releasing clamp
from the ascending aorta.Table 2 – Patients characteristics.
Total Group A
Age 59.98  0.87 59.69  1.0
Sex (male/female) a 119/73 77/55 
NYHA (I./II./III./IV.) a 0/34/133/25 0/25/93/16
Type of disability (I./II./III./IV.) a 18/85/87/2 11/60/59/2
Surgery duration (min) 398.2  4.2 391.8  4.5
Time of EC (min) 299.5  3.1 294.8  3.3
EC arrest (min) 33.6  0.78 33.6  0.93
Extubation b 22 (0–212) 18 (7–212) 
ICU time b 7 (0–42) 7 (2–41) 
Hospitalization time b 12 (2–59) 12 (3–42) 
Pre MPA (mmHg) 53.53  0.75 53.27  0.8
Post MPA (mmHg) 24.72  0.67 25.05  0.8
Difference of MPA 26.8  1.34 25.8  1.61
Pre PVR (dyn s cm5) 873.8  23.6 873.8  27
Post PVR (dyn s cm5) 160  7.7 151.6  9.0
Difference of PVR 705.8  25.5 690.9  30
Pre CI (l/min gm) 2.09  0.04 2.11  0.05
Post CI (l/min gm) 2.9  0.05 2.89  0.06
Difference of CI 0.98  0.08 1.02  0.0
Note: Data are expressed as mean  SEM.
a Absolute frequencies describe categorical variables.
b Non-normal variables are represented by Median (Min  Max).Results
The main characteristics of group A and B and subgroups B1
and B2 are summarized in Table 2.
This list shows the basic demographic data of patients, as
well as clinical disease based on NYHA severity, operation data,
degree and type of disability of pulmonary artery, hemodynam-
ic parameters, total duration of hospitalization, hospitalization
in the intensive care unit (ICU) in days, and duration of
mechanical ventilation in hours (extubation). All these param-
eters are statistically analyzed and the results of these
comparisons are summarized in Table 3. Table 3 also shows
the expected differences in the length of simple and combined
procedure, where the total duration of surgery and duration of
the extracorporeal circulation is greater in combined proce-
dures in group B. Our analysis also shows that patients who
underwent combined procedure are longer artiﬁcially ventilat-
ed, and the time leading to their extubation is signiﬁcantly
longer than in patients who had undergone only PEA.
It is well known that the length of mechanical ventilation is
a major risk factor for post-operative pulmonary inﬂammatory
complications, as its length increases the number of lung
infections. In contrast, a statistically signiﬁcant difference was
observed in gender and age distribution in the groups B1 and
B2. When compared with group A, the difference in the age of
women in group B1-patients with revascularization and
patients in group B2 were signiﬁcantly younger.
If we follow the hemodynamic improvements compared
with the preoperative condition, all groups showed a statistically
signiﬁcant improvement in both a decrease in the pulmonary
vascular resistance (PVR), increase in the cardiac index (CI) and a
decrease in the mean pulmonary artery pressure (MPa).
The effect's summary and comparison of pulmonary
vascular resistance are presented in Graphs 1 and 2 for CI Group B Group B1 Group B2
6 60.61  1.54 65  1.73 56.34  2.51
42/18 20/3 17/12
 0/11/40/9 0/2/17/4 0/7/17/5
 7/25/28/0 3/14/6/0 3/9/17/0
 412.2  8.8 420.5  17.3 400.3  9.8
 309.7  6.5 300.8  10.9 306.7  8.7
 33.6  1.46 29.6  1.88 36.8  2.13
30 (0–202) 29 (0–192) 32 (7–202)
7 (0–42) 10 (0–42) 7 (4–32)
12 (2–59) 12 (2–59) 11.5 (3–40)
7 54.09  1.47 57.59  2.56 54.24  1.76
4 23.93  1.09 22.48  1.20 24.52  1.80
 29.05  2.43 34.57  3.42 28.73  3.23
.5 889.7  45.3 1039.3  91.8 815.5  44.0
 149.5  15.1 124.8  21.0 163.7  24.0
.0 738.5  48.5 925.1  96.8 639.1  48.9
 2.05  0.05 1.99  0.07 2.10  0.08
 2.9  0.08 3.04  0.15 2.88  0.10
9 0.90  0.15 1.05  0.24 0.87  0.23
Table 3 – P-values of the between-group comparisons.
Group A vs. group B Group A vs. group B1 vs. group B2
P-value Global P A vs. B1 A vs. B2 B1 vs. B2
Age 0.628 0.044* 0.107 0.945 0.047*
Sex 0.123 0.031* 0.009** 0.977 0.025*
NYHA 0.832 0.546 0.502 0.463 0.329
Type of disability 0.732 0.194 0.193 0.364 0.057
Surgery duration 0.041* 0.062 0.057 1.000 0.433
Time of EC 0.042* 0.456 1.000 0.703 1.000
Total EC arrest 0.998 0.061 0.213 0.672 0.057
Pre MPA 0.617 0.178 0.191 1.000 0.656
Pre PVR 0.658 0.032* 0.056 1.000 0.042
PRE CI 0.453 0.606 0.960 1.000 1.000
Extubation 0.003** 0.018* 0.731 0.018* 0.797
ICU time 0.335 0.335 0.467 1.000 1.000
Hospitalization time 0.861 0.525 0.937 1.000 0.868
Note: Global P-values are based on the one-way ANOVA and Kruskal–Wallis test for normal and non-normal variables, respectively. Bonferroni
post-hoc test was used for pairwise comparisons. P-values of the categorical variables were derived from the chi-square tests.
* P < 0.05.
** P < 0.01.
Graph 1 – Pulmonary vascular resistance before and after
operation.
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ble results for all groups.
The long-term effect of surgery (PEA) is shown in Graph 4;
cumulative survival rate is comparable for groups A and B2.
Cumulative survival rate is very good with annual survival
in group A – 94%, group B2 – 90% and group B1 – 82.6%. Five-
year survival rate is 83% in group A, 79.3% in group B1, and
63.1% in group B1. Group B1 is statistically signiﬁcantly
different from group A (P = 0.031).
Graph 5 shows the cumulative survival rate of the entire
database.
Discussion
CTEPH is a disease with poor prognosis if not in time indicated
for surgical treatment. Medically treated patients with CTEPH
have a poor prognosis for long-term survival [6]. Surgical
treatment of PEA is a recognized treatment of choice with good
long-term results and with capability of curing this disease
[7,8]. Results of combined interventions are comparable with
isolated pulmonary endarterectomy. We did not ﬁnd any
differences in hemodynamic effects. The only difference
found was in the length of intubation, number of complica-
tions and longer hospitalization. However, early mortality was
comparable in both our groups and the large group published
by the UCSD [3].
In our center, we introduced surgical treatment of patients
with diagnosed ﬁbrillation or atrial ﬂutter with CryoMAZE
[9,10]. This combination of procedures was for the ﬁrst time
performed in 2005, and since then we have operated on the
total of 13 patients, 8 of the 11 living patients (i.e. 72%) have
sinus rhythm after the surgery with an average of 26 months.
Indications for MAZE simultaneously with PEA seem to be
highly beneﬁcial. Sinus rhythm is very important for an
uncomplicated post-operative course and the hemodynamic
stability of the patient. Hemodynamically stable patients
require smaller catecholamine support and even treatment of
right ventricular dysfunction is much faster [11].The differences between patients' samples can also be
caused by a targeted investigation of comorbidities. In
particular, the search for atrial septal defect preoperatively
and intraoperatively, continuous implementation of coronary
angiography in all patients indicated for PEA without any age
limitation carried out in some centers [3,12]. We currently do not
have an age limits, and we simultaneously perform right-sided
catheterization with the injection of bronchopulmonary col-
laterals. We do not search just after stenotic lesions caused by
atherosclerosis, but we also search for stenosis caused by
dilatation of the pulmonary artery and oppression that is rather
dependent on the amount of pressure in the pulmonary artery
and the anatomical arrangement rather than absolute age.
Graph 2 – Cardiac index before and after operation. Graph 4 – Cumulative survival by group.
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about 1–2% of PEA procedures in the largest database from the
UCSD. Aortic valve replacement is the most common
procedure followed by a mitral valve repair. Our patients'
database follows the same pattern as shown in Table 1. The
most affected valve is the tricuspid valve. Valves incompe-
tence is most of the time functional; therefore the resolution of
pulmonary hypertension by pulmonary endarterectomy
resolves the tricuspid valve insufﬁciency and the procedure
is therefore not indicated [13,14]. These results are alsoGraph 3 – Mean pulmonary artery pressure before and after
operation.conﬁrmed from our experience. Japanese authors suggest
that tricuspid valve procedure should be performed due to the
fact that in the most severe patients with right-sided cardiac
insufﬁciency this eases the post-operative course [15]. In their
database analysis they have the largest number of heart
supports for right-sided heart failure [16].
Accurate CTEPH diagnosis and characterization of its
extent and distribution are imperative to allow the prompt
initiation of treatment, particularly surgical pulmonary
endarterectomy in eligible patients [17].Graph 5 – Cumulative survival of the entire patient
database.
c o r e t v a s a 5 7 ( 2 0 1 5 ) e 1 1 5 – e 1 2 0e120Conclusion
Results of combined interventions are comparable with isolated
pulmonary endarterectomy. We did not ﬁnd any differences in
hemodynamic effects. The only difference found was the length
of intubation, number of complications and longer hospitaliza-
tion. However, early mortality was comparable in both our
group and the large data analysis performed by the UCSD All
patients indicated for the PEA should be screened for the most
common comorbidities regardless of their age. We recommend
implementation CryoMAZE for the treatment of atrial ﬁbrilla-
tion or atrial ﬂutter.
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